Adicet Bio Inc (ACET)vsInsmed Inc (INSM)
ACET
Adicet Bio Inc
$6.81
+1.79%
HEALTHCARE · Cap: $66.43M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
ACET leads profitability with a 0.0% profit margin vs -2.1%. ACET appears more attractively valued with a PEG of 0.82. INSM earns a higher WallStSmart Score of 39/100 (F).
ACET
Hold38
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Growing faster than its price suggests
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ACET
The strongest argument for ACET centers on Price/Book, PEG Ratio. PEG of 0.82 suggests the stock is reasonably priced for its growth.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : ACET
The primary concerns for ACET are EPS Growth, Market Cap, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
ACET profiles as a value stock while INSM is a turnaround play — different risk/reward profiles.
ACET carries more volatility with a beta of 1.61 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
ACET generates stronger free cash flow (-21M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 38/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Adicet Bio Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company is headquartered in Boston, Massachusetts.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?